Hypotheses, rationale, design, and methods for prognostic evaluation in type 2 diabetic patients with angiographically normal coronary arteries. The MASS IV-DM Trial
<p>Abstract</p> <p>Background</p> <p>The MASS IV-DM Trial is a large project from a single institution, the Heart Institute (InCor), University of São Paulo Medical School, Brazil to study ventricular function and coronary arteries in patients with type 2 diabetes melli...
Main Authors: | Lemos Pedro, Parga Jose, Tsutsui Jeane, Meneguetti Claudio, Strunz Celia, Pereira Alexandre, Garcia Rosa, Garzillo Cibele, Vieira Ricardo, Lima Eduardo, Gersh Bernard J, Soares Paulo R, Lopes Neuza, Hueb Whady, Hueb Alexandre, Ushida Augusto, Maranhão Raul, Chamone Dalton A, Ramires Jose AF |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-09-01
|
Series: | BMC Cardiovascular Disorders |
Online Access: | http://www.biomedcentral.com/1471-2261/10/47 |
Similar Items
-
Five-year follow-up of angiographic disease progression after medicine, angioplasty, or surgery
by: Oliveira Sergio A, et al.
Published: (2010-10-01) -
Desafios terapêuticos da insuficiência coronariana obstrutiva crônica
by: Whady A. Hueb, et al.
Published: (2003-01-01) -
Desafios terapêuticos da insuficiência coronariana obstrutiva crônica
by: Hueb Whady A., et al.
Published: (2003-01-01) -
A randomized comparative study of patients undergoing myocardial revascularization with or without cardiopulmonary bypass surgery: The MASS III Trial
by: Dallan Luis A, et al.
Published: (2008-08-01) -
Better Technology, More Spending, Worse Outcomes
by: Whady Hueb